Variant report
Variant | esv3436262 |
---|---|
Chromosome Location | chr1:228228329-228232627 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:12)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:12 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr1:228229732..228234338-chr1:228270201..228272073,4 | MCF-7 | breast: | |
2 | chr1:228230593..228233743-chr1:228266811..228273047,6 | MCF-7 | breast: | |
3 | chr1:228218670..228221362-chr1:228227720..228229463,2 | K562 | blood: | |
4 | chr1:228226578..228229200-chr1:228230155..228231993,2 | MCF-7 | breast: | |
5 | chr1:228230710..228233813-chr1:228249288..228252101,3 | MCF-7 | breast: | |
6 | chr1:228230109..228232010-chr1:228259554..228261382,2 | MCF-7 | breast: | |
7 | chr1:228232008..228234474-chr1:228288638..228291094,2 | MCF-7 | breast: | |
8 | chr1:228230050..228232873-chr1:228260583..228263014,2 | MCF-7 | breast: | |
9 | chr1:228225342..228227954-chr1:228229065..228231428,3 | MCF-7 | breast: | |
10 | chr1:228197532..228200122-chr1:228231400..228233499,2 | MCF-7 | breast: | |
11 | chr1:228222291..228225840-chr1:228229698..228232365,4 | MCF-7 | breast: | |
12 | chr1:228226578..228229200-chr1:228230155..228231993,2 | MCF-7 | breast: |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000143761 | chromatin interactions |
ENSG00000143793 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs146604756 | chr1:228228339-228228340 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs371166587 | chr1:228228351-228228352 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs140246938 | chr1:228228359-228228360 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs183411711 | chr1:228228360-228228361 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs531376206 | chr1:228228365-228228366 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs573596237 | chr1:228228400-228228401 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs534199845 | chr1:228228445-228228446 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs555954152 | chr1:228228504-228228505 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs188413137 | chr1:228228516-228228517 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs551381871 | chr1:228228542-228228543 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs11328093 | chr1:228228587-228228588 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs565414510 | chr1:228228589-228228590 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs71754599 | chr1:228228673-228228674 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs4065965 | chr1:228228694-228228695 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs862000 | chr1:228228695-228228696 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs56307641 | chr1:228228714-228228715 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs6143658 | chr1:228228715-228228716 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs201615797 | chr1:228228721-228228722 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs72466984 | chr1:228228722-228228723 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs139744838 | chr1:228228728-228228729 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs149273181 | chr1:228228744-228228745 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs397767394 | chr1:228228750-228228751 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs115352682 | chr1:228228766-228228767 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs35920626 | chr1:228228771-228228772 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs137944139 | chr1:228228793-228228794 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs190068862 | chr1:228228808-228228809 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs149037258 | chr1:228228816-228228817 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs182378175 | chr1:228228873-228228874 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs79352133 | chr1:228228874-228228875 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs552638870 | chr1:228228916-228228917 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs145738866 | chr1:228228941-228228942 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs549957736 | chr1:228228958-228228959 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs571375024 | chr1:228229026-228229027 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs201417246 | chr1:228229040-228229041 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs538703870 | chr1:228229059-228229060 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs186665782 | chr1:228229063-228229064 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs1034792 | chr1:228229067-228229068 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
38 | rs534542583 | chr1:228229097-228229098 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs555774434 | chr1:228229124-228229125 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs567895683 | chr1:228229147-228229148 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs538058504 | chr1:228229198-228229199 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs532632488 | chr1:228229220-228229221 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs375936909 | chr1:228229221-228229222 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs138939297 | chr1:228229251-228229252 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs577729277 | chr1:228229296-228229297 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs545068961 | chr1:228229297-228229298 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs553785933 | chr1:228229320-228229321 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs572341982 | chr1:228229338-228229339 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs373150730 | chr1:228229345-228229346 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs1857142 | chr1:228229357-228229358 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Esophageal squamous carcinoma | 21637470 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Schizophrenia | 19415332 | CNVD |
Autism | 22495311 | CNVD |
Melanoma | 18172304 | CNVD |
Rett syndrome | 21593744 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Cancer | 20164919 | CNVD |
Wilms tumour | 21544195 | CNVD |
Breast cancer | 17133270 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Cervical cancer | 21063398 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 20632083 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Gastrointestinal stromal cancer | 20470368 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Medulloblastoma | 21292688 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Breast cancer | 21264507 | CNVD |
Liposarcoma | 21253554 | CNVD |
Multiple myeloma | 21628407 | CNVD |
Cancer | 16751803 | CNVD |
Prostate cancer | 16705090 | CNVD |
Neuroblastoma | 19435921 | CNVD |
Breast cancer | 17850661 | CNVD |
Breast cancer | 16461572 | CNVD |
Intracranial tumor | 16823260 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Breast cancer | 17603634 | CNVD |
Neuroblastoma | 21899760 | CNVD |
Breast cancer | 21858162 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Breast cancer | 16608533 | CNVD |
Ewing''s sarcoma | 22429812 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Breast cancer | 17001317 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Prostate cancer | 18632612 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Ependymoma | 18628472 | CNVD |
Leukemia | 18628472 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Acute lymphoblastic leukemia | 19100363 | CNVD |
Breast cancer | 21509527 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Chordoma | 18071362 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Urothelial tumor | 18831757 | CNVD |
Lung cancer | 18438408 | CNVD |
Medulloblastoma | 16783165 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Mental retardation | 19951919 | CNVD |
Non-syndromic sensorineural hearing loss | 17873649 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Autism | 14699429 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Fumarase deficiency | 21572526 | CNVD |
Autism | 17483303 | CNVD |
Kartagener syndrome | 16639409 | CNVD |
Congenital abnormalities | 21549014 | CNVD |
Developmental delay | 21549014 | CNVD |
Mental retardation | 21549014 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Glioblastoma multiforme | 21138945 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
Cancer | 20164920 | CNVD |
Cancer | 17060936 | CNVD |
Myelofibrosis | 22110671 | CNVD |
abnormal development | 18461090 | CNVD |
Breast cancer | 21364760 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr1:228225800-228231400 | Weak transcription | Right Atrium | heart |
2 | chr1:228229400-228229800 | Enhancers | Esophagus | oesophagus |
3 | chr1:228229800-228230000 | Weak transcription | Esophagus | oesophagus |
4 | chr1:228230000-228230400 | Enhancers | Esophagus | oesophagus |
5 | chr1:228230400-228230600 | Bivalent Enhancer | Skeletal Muscle Female | skeletal muscle |
6 | chr1:228230400-228232800 | Weak transcription | Esophagus | oesophagus |
7 | chr1:228230600-228231400 | Enhancers | Breast Myoepithelial Primary Cells | Breast |
8 | chr1:228230600-228231400 | Enhancers | A549 | lung |
9 | chr1:228230600-228231600 | Enhancers | HMEC | breast |
10 | chr1:228231000-228231200 | Bivalent Enhancer | iPS DF 19.11 Cell Line | embryonic stem cell |
11 | chr1:228231000-228231400 | Bivalent Enhancer | Stomach Mucosa | stomach |
12 | chr1:228231000-228232000 | Enhancers | Hela-S3 | cervix |
13 | chr1:228231200-228231600 | Enhancers | H1 Derived Mesenchymal Stem Cells | ES cell derived |
14 | chr1:228231400-228231600 | Bivalent Enhancer | Fetal Muscle Leg | muscle |
15 | chr1:228231400-228232600 | Weak transcription | Stomach Mucosa | stomach |
16 | chr1:228231400-228239600 | Weak transcription | Breast Myoepithelial Primary Cells | Breast |
17 | chr1:228232000-228232600 | Weak transcription | Hela-S3 | cervix |
18 | chr1:228232400-228233400 | Bivalent Enhancer | hESC Derived CD56+ Ectoderm Cultured Cells | ES cell derived |
19 | chr1:228232600-228233400 | Bivalent Enhancer | ES-I3 Cell Line | embryonic stem cell |
20 | chr1:228232600-228233400 | Enhancers | Hela-S3 | cervix |
21 | chr1:228232600-228234200 | Enhancers | Stomach Mucosa | stomach |